BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

ASX ANNOUNCEMENT2 March 2010BNC210 Clinical Trial Results...

  1. manfred1952
    613 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    02/03/10
    10:43
    Post #: 6393755
    ASX ANNOUNCEMENT
    2 March 2010
    BNC210 Clinical Trial Results Confirm Safety and Indicate Reduced
    Stress Hormone Levels
    BNC210 reduced blood levels of stress hormone in trial subjects,
    indicating anxiolytic activity
    Stage 2 of trial confirms BNC210 is safe and well tolerated
    Supports potential for once a day oral administration of BNC210


    BNO Price at posting: 31.8¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New channel sampling confirms further copper at Graceland, Namibia
right-arrow Created with Sketch.
NEWS Strategic investment secured for QLD and NSW bauxite projects
right-arrow Created with Sketch.
NEWS View the latest ASX market news here
right-arrow Created with Sketch.
NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.